Diwakar Davar
Clinical trials sponsored by Diwakar Davar, explained in plain language.
-
New drug duo aims to outsmart melanoma that resists standard treatment
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, zimberelimab and domvanalimab, in 8 adults with melanoma that stopped responding to PD-1 inhibitors. The goal is to see if the combination can shrink tumors or stop them from growing. The study is active but …
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo therapy aims to shrink melanoma before surgery
Disease control OngoingThis study tests whether giving one or two immunotherapy drugs before surgery can shrink advanced melanoma (stage III or IV) that can be removed. About 48 adults with operable melanoma will receive either a single drug (dostarlimab) or a combination (dostarlimab plus cobolimab) b…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Poop pills plus immunotherapy: a new hope for melanoma that stopped responding?
Disease control TerminatedThis study aimed to see if adding a healthy donor fecal transplant (FMT) to standard immunotherapy drugs could help people with advanced melanoma that no longer responds to PD-1 inhibitors. The trial was planned for about 30 participants but was withdrawn before anyone enrolled. …
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC